BSE Live
Mar 25, 16:01Prev. Close
1311.20
Open Price
1309.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 25, 15:57Prev. Close
1310.90
Open Price
1326.00
Bid Price (Qty.)
1346.60 (7)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Dr Lal PathLabs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 223.20 | 195.44 | 168.27 | 152.48 | 191.75 | |
| Net CashFlow From Operating Activities | 272.00 | 208.50 | 189.38 | 166.67 | 142.25 | |
| Net Cash Used In Investing Activities | -19.50 | -92.75 | -165.90 | -134.49 | -148.14 | |
| Net Cash Used From Financing Activities | -187.20 | -54.33 | 12.93 | -31.59 | 0.99 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 65.30 | 61.43 | 36.41 | 0.59 | -4.89 | |
| Cash And Cash Equivalents Begin of Year | 124.00 | 62.52 | 26.11 | 25.38 | 22.95 | |
| Cash And Cash Equivalents End Of Year | 189.30 | 123.95 | 62.52 | 25.97 | 18.06 |
12.03.2026
Dr Lal PathLab Standalone December 2025 Net Sales at Rs 632.10 crore, up 19.69% Y-o-Y
12.02.2026
05.02.2026
Dr Lal PathLab Consolidated December 2025 Net Sales at Rs 659.80 crore, up 10.57% Y-o-Y
03.02.2026
Dr Lal PathLab Standalone December 2025 Net Sales at Rs 632.10 crore, up 19.69% Y-o-Y
12.03.2026
Dr Lal PathLab Standalone December 2025 Net Sales at Rs 632.10 crore, up 19.69% Y-o-Y
05.02.2026
Dr Lal PathLab Consolidated December 2025 Net Sales at Rs 659.80 crore, up 10.57% Y-o-Y
03.02.2026
Dr Lal PathLab Standalone December 2025 Net Sales at Rs 632.10 crore, up 19.69% Y-o-Y
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak
25.03.2026
25.03.2026
25.03.2026
24.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth